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Reprogramming of cellular metabolism is crucial for T cells responding to environmental cues. Blagih et al.
(2015) reveal that the kinase AMPK directs metabolic adaption of effector T cells upon nutrient limitation
and contributes to immune responses in vivo.Adaptation of appropriate metabolic pro-
grams is important for T cell responses in
adaptive immunity (Pearce et al., 2013).
Quiescent naive T cells rely on oxidative
phosphorylation (OXPHOS) for ATP gener-
ation through breakdown of nutrients,
whereas activated T cells switch to ana-
bolic metabolism to fuel the increased
bioenergetic and biosynthetic demands
required for robust clonal expansion. In
addition to the distinct metabolic pro-
grams adopted by quiescent and acti-
vated T cells, the metabolic signature of
T cells also varies in distinct T cell lineages.
For instance, CD4+ T helper 1 (Th1), Th2,
and Th17 cell lineages and CD8+ T effector
(Teff) cells display a strong bias toward
glycolysis, whereas regulatory T cells and
CD8+ memory T cells prefer OXPHOS in
mitochondria (Gerriets et al., 2014; Micha-
lek et al., 2011; Pearce et al., 2009; Shi
et al., 2011; Sukumar et al., 2013).
Emerging evidence indicates that the inter-
ference of nutrient transport and utilization
has profound impacts on T cell fate and
function (Pearce et al., 2013). Moreover,
during an immune response, T cells traffic
from nutrient-replete lymphoid organs to
effector sites such as tumor or infection,
where oxygen, nutrients, and growth fac-
tors may be limiting (Pearce et al., 2013).
Such environments with insufficient nu-
trient availability may induce T cells to re-
wire their metabolic programs to ensure
proper survival, effector function, or both.
Compared with our increasing knowledge
of metabolic reprogramming of T cells
upon activation and differentiation, little is
known about the metabolic pathways or
molecular regulators for Teff cells under
limiting nutrient availability, especially dur-
ing immune responses in vivo.
In a recent paper published in Immu-
nity, Blagih et al. (2015) explored the influ-
ence of nutrient limitation on the meta-
bolic reprogramming and function of Teff4 Immunity 42, January 20, 2015 ª2015 Elsevcells. The authors observed that glucose
starvation impaired the proliferation and
the translation of IFN-gmRNA of Teff cells
but had no effect on the transcription of
IFN-g mRNA. This was associated with
the reduced activation of the mechanistic
target of rapamycin complex 1 (mTORC1)
signaling pathway, a crucial regulator of
mRNA translation and immune responses
(Chi, 2012). Limiting the availability of the
other important carbon source, gluta-
mine, also impaired mTORC1 activity in
Teff cells. Therefore, Teff cells require
both glucose and glutamine to maintain
their proliferation and effector function.
The authors next examined the require-
ment of glucose and glutamine in pro-
gramming the cellular metabolism of Teff
cells. In response to decreasing glucose
concentrations, Teff cells dampened the
extracellular acidification rate (ECAR),
indicating impaired glycolytic activity.
However, the mitochondrial oxygen con-
sumption rate (OCR), a measurement of
OXPHOS, was largely maintained under
glucose-free conditions, leading to an
increased OCR/ECAR ratio. Moreover,
mitochondrial spare respiratory capacity
(SRC), which is the extramitochondrial ca-
pacity available in a cell to produce energy
under conditions of increased work or
stress, was also elevated under conditions
of glucose starvation. In sharp contrast,
removal of glutamine from culturemedium
significantly impaired OCR, but not ECAR,
in Teff cells. With regard to cellular bioen-
ergetics, glucose starvation largely main-
tained cellular ATP, whereas glutamine
withdrawal diminished its ATP concentra-
tions in Teff cells. Thus, glutamine fuels
mitochondrial metabolism when glucose
is limiting. Interestingly, glucose limitation
promoted the expression of genes in-
volved in glutamine metabolism such as
the glutamine transporters Snat1 and
Snat2 and glutaminase (Gls), suggestingier Inc.the increased glutaminolysis in glucose-
starved Teff cells. In support of this view,
stable isotope tracer analysis revealed
that glucose-starved Teff cells enhanced
glutamine-derived glutamate and main-
tained tricarboxylic acid (TCA) cycle inter-
mediates. Additionally, glucose-starved
Teff cells engaged a metabolic shunt by
converting glutamine to pyruvate via
decarboxylation of malate, and this reac-
tion provided a pool of glutamine-derived
pyruvate to maintain homeostasis of the
TCA cycle. Therefore, in response to
glucose limitation, Teff cells rewire their
metabolic programs and resort to gluta-
mine metabolism for ATP generation in
mitochondria.
Blagih et al. probed the metabolic regu-
lators that maintain cellular bioenergetics
in Teff cells upon glucose limitation.
AMP-activated protein kinases (AMPKs)
serve as evolutionarily conserved energy
sensors that canbeactivatedby increased
AMP concentrations, indicative of excess
energy expenditure. AMPK activation not
only promotes ATP production through
catabolic pathways but also limits pro-
cesses that consume ATP. As one of the
most energy-consuming processes in the
cells, protein synthesis is positively regu-
latedbymTORC1,whose activity is known
to be suppressed by AMPK (Chi, 2012).
Upon the deprivation of either glucose or
glutamine, Teff cells elevated AMPK activ-
ity. More importantly, AMPK-deficient Teff
cells markedly increasedmTORC1 activa-
tion, associated with the increased trans-
lation of Ifng mRNA at lower glucose con-
centrations. In agreement with this
observation, AMPK agonists AICAR or
phenoformin suppressed IFN-g produc-
tion by wild-type (WT) Teff cells but had
less impact on AMPK-deficient Teff cells.
Collectively, AMPK acts as a metabolic
sensor of nutrient availability, in part by
regulating mRNA translation in Teff cells.
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Figure 1. AMPK Reprograms Metabolic Pathways of Teff Cells in Response to Glucose
Limitation
Under glucose limitation, the ratio of AMP:ATP is elevated, indicating excessive ATP consumption over
production. This alteration induces AMPK activation to restore the energy balance and reprogram cellular
metabolism through two distinct mechanisms. First, AMPK reduces energy expenditure by suppressing
mTORC1 activation and mRNA translation, a prominent ATP-consuming process. Second, AMPK pro-
motes glutamine uptake and oxidation to fuel the TCA cycle andOXPHOS for ATP production inmitochon-
dria. To circumvent the deficient input of glucose-derived pyruvate into the TCA cycle, Teff cells adopt an
alternative metabolic pathway, via decarboxylation of malate, to generate a glutamine-dependent pool of
pyruvate. AMPK-mediated metabolic reprogramming is indispensable for the survival and function of Teff
cells upon glucose limitation and contributes to proper immune responses in T cell-mediated colitis and
anti-viral and bacterial immunity.
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due to AMPK deficiency suggests excess
energy expenditure, but is AMPK
also involved in the control of ATP pro-
duction under nutrient starvation? Closer
examination of metabolism of AMPK-
deficient Teff cells indicated that this is
the case. Blagih et al. found that AMPK-
deficient Teff cells had significantly
reduced OCR and SRC under glucose
limitation, indicative of defective mito-
chondrial metabolism. Also, AMPK-defi-
cient cells showed an elevated ratio of
AMP:ATP and failed to maintain ATP con-
centrations upon glucose withdrawal.
Moreover, AMPK-deficient cells were un-
able to utilize glutamine to fuel the gener-
ation of multiple TCA cycle intermediates.
In the support of this, AMPK deficiency
impaired the upregulation of genes
involved in glutamine metabolism in Teff
cells deprived of glucose. Therefore,
AMPK mediates a key checkpoint in re-
programming cellular metabolism in Teff
cells in response to glucose limitation.To establish the physiological role of
AMPK in immune responses, Blagih
et al. employed T cell-mediated colitis
and infection models with influenza A vi-
rus or a engineered bacterium, L. mono-
cytogenes expressing OVA (LmOVA). In
the colitis model, the deficiency of
AMPK in T cells significantly reduced the
cellularity (but not proportion) of the in-
flammatory Th1 and Th17 cells in the in-
testinal tissues and protected the mice
from the development of colitis. Addition-
ally, mice with T cell-specific deficiency of
AMPK had defective protective immunity,
as indicated by the markedly reduced
numbers of antigen-specific T cells in
the primary immune responses upon
influenza A virus or LmOVA infection.
The result from the LmOVA infection
model is somewhat different from that of
a previous study, in which AMPK was
found to be dispensable for antigen-spe-
cific CD8+ T cells in response to LmOVA
challenge (Rolf et al., 2013). This inconsis-
tency could be due to the different exper-Immunityimental systems and approaches used.
Furthermore, AMPK-deficient Teff cells
displayed defective survival and meta-
bolism in vivo. By evaluating metabolic
profiles of antigen-specific T cells, Blagih
et al. revealed that AMPK deficiency re-
sulted in the reduction of OCR, SRC,
glutamine metabolism, and ATP produc-
tion. Therefore, AMPK links metabolic ho-
meostasis and energy maintenance to
effector functions in vivo.
Overall, this work provides important
insights into our understanding of meta-
bolic plasticity of T cell responses and
highlights a crucial role of AMPK in re-
programing metabolic pathways of Teff
cells in response to glucose insufficiency.
AMPK employs two strategies in this pro-
cess to maintain energetic homeostasis
under conditions of nutrient stress: by di-
minishing energy expenditure through
downregulating mTORC1 activation and
cytokine mRNA translation and by
engaging glutamine-dependent OXPHOS
for ATP production (Figure 1). Going for-
ward, it will be interesting to decipher
the mechanisms underlying AMPK-medi-
ated glutamine metabolism and energy
maintenance upon glucose limitation.
Here we speculate on several possibil-
ities. First, given the crucial role of the
transcription factor c-Myc in mediating
glutamine metabolism of T cells (Wang
et al., 2011), it is possible that AMPK inter-
sects with c-Myc function in maintaining
energy balance in Teff cells. Second,
glucose starvation can promote the in-
duction of autophagy, which may con-
tribute to AMPK-dependent metabolic
reprogramming. Finally, AMPK agonists
promote the generation of CD8+ memory
T cells through activating fatty acid oxida-
tion (FAO) (Pearce et al., 2009), and thus
glutamine metabolism may coordinate
with FAO for metabolic reprogramming
and ATP maintenance in Teff cells re-
sponding to nutrient insufficiency. Indeed,
given that blocking glycolysis in Teff cells
promotes the generation of memory
T cells (Sukumar et al., 2013), the meta-
bolic microenvironment may have a
fundamental role in the differentiation of
Teff and memory T cells.
The study by Blagih et al. reveals an
exciting model for how Teff cells repro-
gram their metabolism to maintain their
survival and function upon limited nutrient
availability. Aside from the energy check-
point, other metabolic checkpoints have42, January 20, 2015 ª2015 Elsevier Inc. 5
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Previewsbeen proposed in regulating T cell re-
sponses (Pearce et al., 2013), whereas
their impacts on the fate and function of
Teff cells remain to be elucidated. The
further understanding of the interconnec-
tion between environmental nutrient avail-
ability and metabolic reprogramming of
T cells will likely provide new insights
and strategies to improve immune re-
sponses or vaccine efficacy under meta-
bolically restrictive environments.
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Notch receptors are widely expressed and have recognized functions in thymocytes and mature T cells.
In this issue, Laky et al. (2015) show that Notch interactions with Delta-like ligand 4 (DLL4) amplify priming
of naive T cells.There are four mammalian Notch genes,
with Notch1, Notch2, and Notch3 known
to have important roles in thymopoiesis
and the differentiation of CD4+ helper
T cells in the periphery (Radtke et al.,
2013). Notch receptors are capable of
interacting with five ligands, including
Jagged1, Jagged2, Delta-like ligand 1
(DLL1), DLL3, and DLL4 (Radtke et al.,
2013). Ligation of Notch by its ligands re-
sults in proteolytic cleavage of the intra-
cellular domain by gamma secretase.
The resulting subunit, according to what
is called ‘‘canonical signaling,’’ is traf-
ficked to the nucleus, where it coactivates
a number of genes via transcription fac-
tors including RBP-Jk. In noncanonical
signaling, the Notch intracellular domain
drives the transcription of genes indepen-
dently of RBP-Jk. One such route that
has shown relevance in Notch-associatedT cell leukemias entails direct interaction
of the Notch intracellular domain with the
NF-kB signaling pathway (Vilimas et al.,
2007). Effector functions of CD4+ T cells
are augmented by Notch signaling, and
the pattern of Notch ligands on antigen-
presenting cells (APCs) has been shown
to drive differentiation of the various T
helper (Th) lineages (Radtke et al., 2013).
Although its importance inTcell differen-
tiation is well established, the role of Notch
signaling in the priming of naive cells is not
as well studied. Experiments with gamma-
secretase inhibitors (GSIs) have shown
that Notch signaling enhances signals of
the T cell receptor, resulting in increased
expression of activation markers and
proliferation (Adler et al., 2003; Palaga
et al., 2003). Furthermore, overexpression
of the intracellular domain of Notch1 en-
hances T cell proliferation (Adler et al.,2003). In this issue of Immunity, Laky
et al. (2015) add to our knowledge of
Notch signaling during the activation of
naive T cells with reductionist experiments
demonstrating a costimulatory role for
Notch-DLL4 interactions in T cell priming.
To precisely control activation condi-
tions, Laky et al. transfected CD80+ and
CD80 fibroblast lines expressing major
histocompatibility complex (MHC) class
II glycoproteins and the integrin ICAM-1
with physiological amounts of DLL4.
Naive CD4+ T cells showed increased
sensitivity to antigen in the presence of
DLL4, with enhanced CD69 upregulation
and proliferation over a wide range of an-
tigen concentrations. Interestingly, DLL4,
which was found to be expressed on
a subset of CD11c+ splenic dendritic
cells, enhanced T cell activation only if
there was concomitant signaling through
